Stem Cell Therapy For Stroke Patients
Source: Veristat, Inc.

A client engaged the Veristat team in a Phase II study of intracerebral stem cell injection in patients following an ischemic stroke. The goal was to look at limb recovery time and level in patients with stroke. The effort began with identifying the best time for a product to be delivered and then expanded into full-service involvement, including project management, clinical monitoring, monitoring, safety, medical monitoring, medical and regulatory affairs.
Study Demographics
Phase II Multi-Center Efficacy Study
Primary Services Provided:
- Project Management
- Clinical Monitoring
- Medical Writing
- Regulatory Affairs
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
Veristat, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more